Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Benedikt Kolbrink"'
Autor:
Hauke S. Wülfrath, Thorben Schrumpf, Friedrich A. von Samson-Himmelstjerna, Jakob Voran, Yao Zhang, Grit Esser, Sarah-Yasmin Thomsen, Maja L. Messtorff, Theresa Riebeling, Nassim Kakavand, Roland Schmitt, Kevin Schulte, Benedikt Kolbrink
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-7 (2024)
Abstract Background Peritoneal dialysis (PD) remains underutilised in Germany, prompting the initiation of the Sustainable Intensification of Peritoneal Dialysis in Schleswig–Holstein (SKIP-SH) project. The SKIP-SH cohort study aims to demonstrate
Externí odkaz:
https://doaj.org/article/fd6c74d62b6c46bcbefe7c34d77ab353
Autor:
Friedrich A. von Samson-Himmelstjerna, Benedikt Kolbrink, Nassim Kakavand, Helena U. Zacharias, Kevin Schulte
Publikováno v:
Kidney International Reports, Vol 8, Iss 12, Pp 2701-2708 (2023)
Introduction: The time from dialysis onset to enrollment on the kidney waiting list (listing time) is a crucial step on the path to receiving a kidney allograft; however, this process has received very little research attention in the Eurotransplant
Externí odkaz:
https://doaj.org/article/4a18de073d14475690e93af674093290
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/1801e1340cb746568f10efac7d34bf0f
Autor:
Julia Weinmann-Menke, Uwe Heemann, Kerstin Amann, Friedrich Alexander von Samson-Himmelstjerna, Grit Esser, Kevin Schulte, Benedikt Kolbrink, Markus Krautter, Vedat Schwenger, Julia Matschkal, Florian Schraml, Anne Pahl, Matthias Braunisch, Thorsten Feldkamp, Ulrich Kunzendorf, Lutz Renders
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Introduction Despite continued efforts, long-term outcomes of kidney transplantation remain unsatisfactory. Kidney graft rejections are independent risk factors for graft failure. At the participating centres of the TRAnsplant BIOpsies study group, a
Externí odkaz:
https://doaj.org/article/b56a5dd851d34cfe9227654982c13f71
Autor:
Friedrich Alexander von Samson-Himmelstjerna, Benedikt Kolbrink, Theresa Riebeling, Ulrich Kunzendorf, Stefan Krautwald
Publikováno v:
Cells, Vol 11, Iss 14, p 2134 (2022)
Ten years after its initial description, ferroptosis has emerged as the most intensely studied entity among the non-apoptotic forms of regulated cell death. The molecular features of ferroptotic cell death and its functional role have been characteri
Externí odkaz:
https://doaj.org/article/9da857f7905f4d5e90fd4116e043263d
Publikováno v:
IDCases, Vol 24, Iss , Pp e01108- (2021)
An abscess is a common complication after surgical interventions. Furthermore, abscesses of different genesis often occur under immunosuppression. In the case of a kidney transplant patient described here, however, the cause of an abscess-like mass i
Externí odkaz:
https://doaj.org/article/e0f0936792de46529b80d1381d8cb1be
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Necroptosis and pyroptosis are two forms of regulated cell death. They are executed by the proteins mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD), respectively. Once activated by numerous pathways, these proteins form membrane pores
Externí odkaz:
https://doaj.org/article/5e075319156c4ad7bcb954cd7bf681a0
Autor:
Grit Esser, Benedikt Kolbrink, Christoph Borzikowsky, Ulrich Kunzendorf, Thorsten Feldkamp, Kevin Schulte
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242724 (2020)
BackgroundSince 2010, the number of organ donations in Germany has decreased by one third, mostly due to undetected organ donors. It is unclear, how the undetected potential donor pool is distributed among the different German hospital categories (A
Externí odkaz:
https://doaj.org/article/e506d26bcb4b4ba4ab10a3d0b8394979
Autor:
Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann, Benedikt Kolbrink, Kevin Schulte, Anja Gäckler, Andreas Kribben, Kristina Boss, Sebastian A. Potthoff, Lars C. Rump, Tilman Schmidt, Anja S. Mühlfeld, Karsten Schulmann, Matthias Hermann, Jens Gaedeke, Kristin Sauerland, Jörn Bramstedt, Ulrich P. Hinkel, Wolfgang Miesbach, Frederic Bauer, Timm H. Westhoff, Heike Bruck, Veronika Buxhofer-Ausch, Tobias J. Müller, Ralph Wendt, Ana Harth, Adrian Schreiber, Evelyn Seelow, Markus Tölle, Christopher Gohlisch, Markus Bieringer, Gesa Geuther, Wolfram J. Jabs, Michael Fischereder, Anke von Bergwelt-Baildon, Ulf Schönermarck, Paul Knoebl, Jan Menne, Paul T. Brinkkoetter, Fedai Özcan, Silke Markau, Matthias Girndt, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Vedat Schwenger, Maximilian Roeder, Jörg Radermacher, Anke Morgner, Regina Herbst, Charis von Auer
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:559-572
BACKGROUND: The von Willebrand factor-directed nanobody caplacizumab has greatly changed the treatment of immune thrombotic thrombocytopenic purpura (iTTP) in recent years. Data from randomized controlled trials established efficacy and safety. OBJEC
Autor:
Benedikt Kolbrink, Katrin Schüssel, Friedrich A von Samson-Himmelstjerna, Grit Esser, Jürgen Floege, Ulrich Kunzendorf, Kevin Schulte
Publikováno v:
Nephrology Dialysis Transplantation.
Background Outcome data regarding clinically-relevant endpoints after starting dialysis for end-stage renal disease (ESRD) are sparse, and early events after starting dialysis are particularly underestimated. The aim of this study was to describe pat